APO RESEARCH · REPORT
Insulin
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
Product & engineering
Understand the product.
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
Selected research
Market Structure
Global Insulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
The major players in China Insulin market include Novo Nordisk, Eli Lilly, etc. The top 2 players occupy about 60% shares of the whole market. Tianjin and Jiangsu are main markets, they occupy about 60% of the whole market. Regular Human Insulin is the main type, with a share over 60%. Long Acting and Intermediate Acting are the main applications, which holds a share about 70%.
This report provides an overview of the global Insulin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Insulin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Insulin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Insulin market size, projected growth trends, production technologies, key applications, and end-use industries.
Insulin Segment by Company
Novo Nordisk
Eli Lilly
Sanofi-Aventis
Tonghua Dongbao
Ganlee
United Laboratory
Jiangsu Wanbang
Insulin Segment by Type
Animal Insulin
Regular Human Insulin
Insulin Analogue
Insulin Segment by Application
Short Acting
Intermediate Acting
Long Acting
Pre-Mix Insulin
Insulin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Insulin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Insulin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Insulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Insulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Insulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Animal Insulin
- Regular Human Insulin
- Insulin Analogue
Applications
- Short Acting
- Intermediate Acting
- Long Acting
- Pre-Mix Insulin
Companies covered
- Novo Nordisk
- Eli Lilly
- Sanofi-Aventis
- Tonghua Dongbao
- Ganlee
- United Laboratory
- Jiangsu Wanbang
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Insulin Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Insulin Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Insulin Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Insulin Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Insulin Market Dynamics
- 2.1 Insulin Industry Trends
- 2.2 Insulin Industry Drivers
- 2.3 Insulin Industry Opportunities and Challenges
- 2.4 Insulin Industry Restraints
3 Insulin Market by Manufacturers
- 3.1 Global Insulin Revenue by Manufacturers (2021-2026)
- 3.2 Global Insulin Sales by Manufacturers (2021-2026)
- 3.3 Global Insulin Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Insulin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Insulin Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Insulin Manufacturers, Product Type & Application
- 3.7 Global Insulin Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Insulin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Insulin Players Market Share by Revenue in 2025
- 3.8.3 2025 Insulin Tier 1, Tier 2, and Tier 3
4 Insulin Market by Type
- 4.1 Insulin Type Introduction
- 4.1.1 Animal Insulin
- 4.1.2 Regular Human Insulin
- 4.1.3 Insulin Analogue
- 4.2 Global Insulin Sales by Type
- 4.2.1 Global Insulin Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Insulin Sales by Type (2021-2032)
- 4.2.3 Global Insulin Sales Market Share by Type (2021-2032)
- 4.3 Global Insulin Revenue by Type
- 4.3.1 Global Insulin Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Insulin Revenue by Type (2021-2032)
- 4.3.3 Global Insulin Revenue Market Share by Type (2021-2032)
5 Insulin Market by Application
- 5.1 Insulin Application Introduction
- 5.1.1 Short Acting
- 5.1.2 Intermediate Acting
- 5.1.3 Long Acting
- 5.1.4 Pre-Mix Insulin
- 5.2 Global Insulin Sales by Application
- 5.2.1 Global Insulin Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Insulin Sales by Application (2021-2032)
- 5.2.3 Global Insulin Sales Market Share by Application (2021-2032)
- 5.3 Global Insulin Revenue by Application
- 5.3.1 Global Insulin Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Insulin Revenue by Application (2021-2032)
- 5.3.3 Global Insulin Revenue Market Share by Application (2021-2032)
6 Global Insulin Sales by Region
- 6.1 Global Insulin Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Insulin Sales by Region (2021-2032)
- 6.2.1 Global Insulin Sales by Region (2021-2026)
- 6.2.2 Global Insulin Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Insulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Insulin Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Insulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Insulin Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Insulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Insulin Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Insulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Insulin Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Insulin Revenue by Region
- 7.1 Global Insulin Revenue by Region
- 7.1.1 Global Insulin Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Insulin Revenue by Region (2021-2026)
- 7.1.3 Global Insulin Revenue by Region (2027-2032)
- 7.1.4 Global Insulin Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Insulin Revenue (2021-2032)
- 7.2.2 North America Insulin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Insulin Revenue (2021-2032)
- 7.3.2 Europe Insulin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Insulin Revenue (2021-2032)
- 7.4.2 Asia-Pacific Insulin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Insulin Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Insulin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Novo Nordisk
- 8.1.1 Novo Nordisk Company Information
- 8.1.2 Novo Nordisk Business Overview
- 8.1.3 Novo Nordisk Insulin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Novo Nordisk Insulin Product Portfolio
- 8.1.5 Novo Nordisk Recent Developments
- 8.2 Eli Lilly
- 8.2.1 Eli Lilly Company Information
- 8.2.2 Eli Lilly Business Overview
- 8.2.3 Eli Lilly Insulin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Eli Lilly Insulin Product Portfolio
- 8.2.5 Eli Lilly Recent Developments
- 8.3 Sanofi-Aventis
- 8.3.1 Sanofi-Aventis Company Information
- 8.3.2 Sanofi-Aventis Business Overview
- 8.3.3 Sanofi-Aventis Insulin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Sanofi-Aventis Insulin Product Portfolio
- 8.3.5 Sanofi-Aventis Recent Developments
- 8.4 Tonghua Dongbao
- 8.4.1 Tonghua Dongbao Company Information
- 8.4.2 Tonghua Dongbao Business Overview
- 8.4.3 Tonghua Dongbao Insulin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Tonghua Dongbao Insulin Product Portfolio
- 8.4.5 Tonghua Dongbao Recent Developments
- 8.5 Ganlee
- 8.5.1 Ganlee Company Information
- 8.5.2 Ganlee Business Overview
- 8.5.3 Ganlee Insulin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Ganlee Insulin Product Portfolio
- 8.5.5 Ganlee Recent Developments
- 8.6 United Laboratory
- 8.6.1 United Laboratory Company Information
- 8.6.2 United Laboratory Business Overview
- 8.6.3 United Laboratory Insulin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 United Laboratory Insulin Product Portfolio
- 8.6.5 United Laboratory Recent Developments
- 8.7 Jiangsu Wanbang
- 8.7.1 Jiangsu Wanbang Company Information
- 8.7.2 Jiangsu Wanbang Business Overview
- 8.7.3 Jiangsu Wanbang Insulin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Jiangsu Wanbang Insulin Product Portfolio
- 8.7.5 Jiangsu Wanbang Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Insulin Value Chain Analysis
- 9.1.1 Insulin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Insulin Production Mode & Process
- 9.2 Insulin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Insulin Distributors
- 9.2.3 Insulin Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst